Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118436) titled 'A clinical study of probiotics combined with prebiotics to improve the perioperative prognosis of patients with rectal cancer with neoadjuvant chemotherapy' on Feb. 5.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Second Affiliated Hospital of Nanchang University
Condition:
Rectal cancer
Intervention:
intervention group:Oral probiotics (Clostridium butyricum live bacteria capsules, 1260 mg per dose, twice daily) and prebiotics (inulin rich in fructooligosaccharides, 6 g per dose, once daily)
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2024-10-10 ...